Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
662 studies found for:    Open Studies | "Hepatitis"
Show Display Options
Rank Status Study
21 Recruiting Rapid Diagnostics for HIV and Hepatitis
Conditions: HIV Infections;   Hepatitis B Infections;   Hepatitis C Infections
Intervention: Device: Multiplo HBc/HIV/HCV and Reveal HBsAg
22 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
23 Recruiting De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
Condition: De Novo Autoimmune Hepatitis
Interventions: Other: Pediatric transplant subject with d-AIH;   Other: Pediatric transplant subject with acute rejection;   Other: Pediatric transplant subject with chronic rejection;   Other: Adult non-transplant patients with auto-immune hepatitis;   Other: Adult non-transplant subjects with chronic hepatitis C virus;   Other: Pediatric control subjects;   Other: Adult transplanted subjects with de novo autoimmune hepatitis
24 Recruiting A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
Conditions: Hepatitis E;   Hepatitis B
Interventions: Biological: HEV vaccine;   Biological: HBV vaccine
25 Recruiting DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
Conditions: Chronic Hepatitis;   Hepatitis C Infection
Interventions: Biological: DNA Plasmid Encoding Interleukin-12 INO-9012;   Biological: Electroporation-Mediated Plasmid DNA Vaccine Therapy;   Biological: HCV DNA Vaccine INO-8000;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
26 Recruiting Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
Conditions: Advanced Melanoma;   Hepatitis B;   Hepatitis C
27 Unknown  Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Interferon Deficiency
Intervention: Drug: interferon alpha 2b
28 Recruiting HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Condition: Hepatitis C
29 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
30 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
31 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
32 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
33 Recruiting Immune Response in Patients With Hepatitis B and C Infection
Conditions: Hepatitis B;   Hepatitis C
34 Recruiting Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C
Condition: Chronic Hepatitis C
35 Recruiting The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Other: Low Salt Diet;   Other: Liberal salt diet
36 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
37 Recruiting Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study
Condition: Chronic Hepatitis C
38 Unknown  Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment
Conditions: Hepatitis;   Tuberculosis;   hepatitisB
Intervention: Drug: entecavir (BARACLUDE®)
39 Recruiting Seroprevalence of Hepatitis E in People With an Organ Transplant
Condition: Hepatitis E
40 Unknown  Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
Condition: Chronic Hepatitis C
Intervention: Drug: Peg-Interferon alpha2a plus Ribavirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years